Altered lymph node composition in diphtheria toxin receptor-based mouse models to ablate dendritic cells

Journal of Immunology

Volumn 194, Issue 1, 2015, Pages 307-315

  Van Blijswijk, Janneke ^a   Schraml, Barbara U ^a,b   Rogers, Neil C ^a   Whitney, Paul G ^a,c   Zelenay, Santiago ^a   Acton, Sophie E ^a   Sousa, Caetano Reis E ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; UNCLASSIFIED DRUG; CLEC9A PROTEIN, MOUSE; DIPHTHERIA TOXIN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN RECEPTOR; LECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; HYPOCELLULARITY; LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SPLEEN; ANIMAL; ANIMAL MODEL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD11C; BONE MARROW CELLS; DENDRITIC CELLS; DIPHTHERIA TOXIN; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; LECTINS, C-TYPE; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; RECEPTORS, IMMUNOLOGIC; SPLEEN;

EID: 84919628515     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401999     Document Type: Article

References (30)

1. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
2. Hashimoto, D., J. Miller, and M. Merad. 2011. Dendritic cell and macrophage heterogeneity in vivo. Immunity 35: 323-335.
3. Heath, W. R., and F. R. Carbone. 2009. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10: 1237-1244.
4. Steinman, R. M., and J. Idoyaga. 2010. Features of the dendritic cell lineage. Immunol. Rev. 234: 5-17.
5. Schraml, B. U., J. van Blijswijk, S. Zelenay, P. G.Whitney, A. Filby, S. E. Acton, N. C. Rogers, N. Moncaut, J. J. Carvajal, and C. Reis e Sousa. 2013. Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell 154: 843-858.
6. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-Associated antigens. Immunity 17: 211-220.
7. Higashiyama, S., H. Iwabuki, C. Morimoto, M. Hieda, H. Inoue, and N. Matsushita. 2008. Membrane-Anchored growth factors, the epidermal growth factor family: Beyond receptor ligands. Cancer Sci. 99: 214-220.
8. Saito, M., T. Iwawaki, C. Taya, H. Yonekawa, M. Noda, Y. Inui, E. Mekada, Y. Kimata, A. Tsuru, and K. Kohno. 2001. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 19: 746-750.
9. Zaft, T., A. Sapoznikov, R. Krauthgamer, D. R. Littman, and S. Jung. 2005. CD11chigh dendritic cell ablation impairs lymphopenia-driven proliferation of naive and memory CD8+ T cells. J. Immunol. 175: 6428-6435.
10. Hochweller, K., J. Striegler, G. J. Hämmerling, and N. Garbi. 2008. A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. Eur. J. Immunol. 38: 2776-2783.
11. Probst, H. C., K. Tschannen, B. Odermatt, R. Schwendener, R. M. Zinkernagel, and M. Van Den Broek. 2005. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin. Exp. Immunol. 141: 398-404.
12. Meredith, M. M., K. Liu, G. Darrasse-Jeze, A. O. Kamphorst, H. A. Schreiber, P. Guermonprez, J. Idoyaga, C. Cheong, K. H. Yao, R. E. Niec, and M. C. Nussenzweig. 2012. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J. Exp. Med. 209: 1153-1165.
13. Bennett, C. L., E. van Rijn, S. Jung, K. Inaba, R. M. Steinman, M. L. Kapsenberg, and B. E. Clausen. 2005. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169: 569-576.
14. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
15. Swiecki, M., S. Gilfillan, W. Vermi, Y. Wang, and M. Colonna. 2010. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8+ T cell accrual. Immunity 33: 955-966.
16. Takagi, H., T. Fukaya, K. Eizumi, Y. Sato, K. Sato, A. Shibazaki, H. Otsuka, A. Hijikata, T. Watanabe, O. Ohara, et al. 2011. Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 35: 958-971.
17. Fukaya, T., R. Murakami, H. Takagi, K. Sato, Y. Sato, H. Otsuka, M. Ohno, A. Hijikata, O. Ohara, M. Hikida, et al. 2012. Conditional ablation of CD205+ conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo. Proc. Natl. Acad. Sci. USA 109: 11288-11293.
18. Piva, L., P. Tetlak, C. Claser, K. Karjalainen, L. Renia, and C. Ruedl. 2012. Cutting edge: Clec9A+ dendritic cells mediate the development of experimental cerebral malaria. J. Immunol. 189: 1128-1132.
19. van Blijswijk, J., B. U. Schraml, and C. Reis e Sousa. 2013. Advantages and limitations of mouse models to deplete dendritic cells. Eur. J. Immunol. 43: 22-26.
20. Tittel, A. P., C. Heuser, C. Ohliger, C. Llanto, S. Yona, G. J. Hämmerling, D. R. Engel, N. Garbi, and C. Kurts. 2012. Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nat. Methods 9: 385-390.
21. Jiao, J., A.-C. Dragomir, P. Kocabayoglu, A. H. Rahman, A. Chow, D. Hashimoto, M. Leboeuf, T. Kraus, T. Moran, G. Carrasco-Avino, et al. 2014. Central role of conventional dendritic cells in regulation of bone marrow release and survival of neutrophils. J. Immunol. 192: 3374-3382.
22. Friedrich, G., and P. Soriano. 1991. Promoter traps in embryonic stem cells: A genetic screen to identify and mutate developmental genes in mice. Genes Dev. 5: 1513-1523.
23. Buch, T., F. L. Heppner, C. Tertilt, T. J. A. J. Heinen, M. Kremer, F. T. Wunderlich, S. Jung, and A. Waisman. 2005. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2: 419-426.
24. Caton, M. L., M. R. Smith-Raska, and B. Reizis. 2007. Notch-RBP-J signaling controls the homeostasis of CD82 dendritic cells in the spleen. J. Exp. Med. 204: 1653-1664.
25. Rickert, R. C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cremediated mutagenesis in mice. Nucleic Acids Res. 25: 1317-1318.
26. Lahl, K., C. Loddenkemper, C. Drouin, J. Freyer, J. Arnason, G. Eberl, A. Hamann, H. Wagner, J. Huehn, and T. Sparwasser. 2007. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204: 57-63.
27. Sun, C.-M., J. A. Hall, R. B. Blank, N. Bouladoux, M. Oukka, J. R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204: 1775-1785.
28. Moussion, C., and J.-P. Girard. 2011. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 479: 542-546.
29. Wendland, M., S. Willenzon, J. Kocks, A. C. Davalos-Misslitz, S. I. Hammerschmidt, K. Schumann, E. Kremmer, M. Sixt, A. Hoffmeyer, O. Pabst, and R. Förster. 2011. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity 35: 945-957.
30. van de Pavert, S. A., M. Ferreira, R. G. Domingues, H. Ribeiro, R. Molenaar, L. Moreira-Santos, F. F. Almeida, S. Ibiza, I. Barbosa, G. Goverse, et al. 2014. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508: 123-127.